Evidence map›Paper›PMID 17009075›Full record

ArticleClinical and experimental nephrology2006

Abnormal glycosylation of serum IgG in patients with IgA nephropathy.

Hideki Homma, Keiichi Tozawa, Takahiro Yasui, Yasunori Itoh, Yutaro Hayashi, Kenjiro Kohri

Abstract readComparative StudyEvaluation Study
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Reversed-phase separation methods for glycan analysis.Analytical and bioanalytical chemistry · 2017
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hideki HommaDepartment of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. mie-mew@d8.dion.ne.jp
Keiichi Tozawa
Takahiro Yasui
Yasunori Itoh
Yutaro Hayashi
Kenjiro Kohri
Nagoya City University · JPMizuho (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe postulated that IgA nephropathy (IgAN) involved alterations of serum IgG. The present study was undertaken to elucidate changes in serum IgG oligosaccharide structure analysis and to assess the diagnostic usefulness of this analysis in IgAN.

methodsThe subjects were 28 children who were definitively diagnosed as having IgAN on the basis of renal biopsy and who had not received treatment for this disease; 27 healthy children; 15 untreated adults definitely diagnosed as having IgAN; 5 patients with other nephropathies; and 61 healthy adults. Oligosaccharide analyses of IgG were performed by reverse-phase high-performance liquid chromatography (HPLC) developed by Takahashi and colleagues.

resultsIn both the children and the adults, the peak area ratio of isomers with two different galactosyl-N-acetylglucosamine (Gal-GlcNAc) binding sites was significantly lower in the presence of IgAN than in the healthy subjects (P<0.05 in children and P<0.001 in adults). The ratio of Gal-free oligosaccharides to Gal-positive oligosaccharides did not differ according to the presence or absence of IgAN in children or in adults.

conclusionsThe analysis of the oligosaccharide structure of serum IgG seems to be useful in diagnosing IgAN.

Indexed as

AdolescentAdultBiopsyChildChild, PreschoolChromatography, High Pressure LiquidFemaleGlomerulonephritis, IGAGlycoproteinsGlycosylationHumansImmunoglobulin GKidneyMaleMiddle AgedOligosaccharidesGlycoproteinsglycosylated IgGImmunoglobulin GOligosaccharides

Identifiers

PMID17009075
OpenAlexW2044044843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.